Michael J Wilkinson

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Cardiovascular Risk Factors

Cardiovascular Disease

Placebo Controlled

Top Venues

Journal of the American Heart Association

Journal of clinical medicine

Current cardiology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Michael J Wilkinson, Archna Bajaj, Margaret E Brousseau, Pam R Taub
Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran. Journal of the American Heart Association 13 (6) (2024)
Michael J Wilkinson, Archna Bajaj, Margaret E Brousseau, Pam R Taub
Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran. Journal of the American Heart Association 13 (6) (2024)
Michael J Wilkinson, Archna Bajaj, Margaret E Brousseau, Pam R Taub
Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran. Journal of the American Heart Association 13 (6) (2024)
Michael J Wilkinson, Archna Bajaj, Margaret E Brousseau, Pam R Taub
Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran. Journal of the American Heart Association 13 (6) (2024)
Michael J Wilkinson, Archna Bajaj, Margaret E Brousseau, Pam R Taub
Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran. Journal of the American Heart Association 13 (6) (2024)
Michael J Wilkinson, Archna Bajaj, Margaret E Brousseau, Pam R Taub
Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran. Journal of the American Heart Association (2024)
Michael J Wilkinson, Norman E Lepor, Erin Donelly Michos
Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum. Journal of the American Heart Association (2023)
Gary S Ma, Tommy T Chiou, Michael J Wilkinson
Is Lipoprotein(a) Clinically Actionable with Today's Evidence? The Answer is Yes. Current cardiology reports (2023)
Harpreet S Bhatia, Michael J Wilkinson
Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies. Journal of clinical medicine 11 (20) (2022)